How do you spot CBD scams and misleading claims?

Claims to "cure," "treat," or "heal" arthritis or any disease

These claims are illegal under FDA and FTC rules. The FDA has issued 79 or more warning letters since 2015 to companies making disease treatment claims for CBD. The FTC's Operation CBDeceit (December 2020) sanctioned six companies specifically for claims including "medically proven" pain relief and "more effective than OxyContin." No CBD product is approved to treat any disease.

Source: ^{(FTC CBDeceit 2020)(Morris 2021)}

No Certificate of Analysis (COA) available

A Certificate of Analysis is a third-party lab report showing what is actually in the product. If a company does not provide one for your specific product batch, you have no independent way to verify the CBD content, THC content, or whether the product contains lead, pesticides, or other contaminants. Studies find that about 4 out of 10 edible CBD products contain detectable lead. A COA is the only consumer protection available in the absence of FDA premarket review.

Source: Kinghorn et al., Sci Total Environ, 2022. Full COA reading guide.

Health claims on product labels or packaging

CBD products cannot legally claim to treat, diagnose, cure, or prevent any disease on their labels. If the product label says something like "relieves arthritis pain," "treats inflammation," or "supports joint health" — particularly without a required FDA disclaimer — the company may be violating federal law.

Celebrity endorsements presented as medical evidence

Fake celebrity endorsements are a documented scam pattern in the CBD market. If a celebrity's name or image appears in a CBD advertisement but not on that celebrity's verified social media or official channels, the endorsement is likely fabricated. Even real celebrity endorsements are not medical evidence — they are marketing.

Pressure to buy quickly (urgency language, limited-time offers)

Language like "only 3 left," "offer expires tonight," or "free trial — just pay shipping" is designed to prevent you from doing research. Free trial offers that convert to recurring charges without clear disclosure are documented scam patterns that disproportionately affect older adults. The FTC has brought cases against companies using these tactics.

Prices significantly below market rate

Quality CBD extraction, testing, and packaging has real costs. Products priced far below competitors may contain less CBD than labeled, may use cheaper extraction methods that leave residual solvents, or may not be third-party tested at all. Studies find that products priced at the low end are more likely to be mislabeled.

"Proprietary blend" without specific cannabinoid content

A product that lists a "proprietary hemp blend" but does not disclose how much CBD it contains is not verifiable. Without a specific CBD content claim and a COA to back it up, you do not know what you are buying.

Claims of FDA approval

No CBD product is FDA-approved for arthritis, chronic pain, or any musculoskeletal condition. The only FDA-approved CBD product is Epidiolex, a prescription drug for specific seizure disorders. Any claim that a CBD supplement or topical is "FDA-approved" is false.

"Big Pharma doesn't want you to know" or similar conspiracy framing

Academic research identifies conspiracy framing as a hallmark of supplement marketing. The FTC's consumer guidance specifically warns against "miracle" health claims paired with anti-establishment language. This framing is designed to discourage you from checking with your doctor or doing independent research.

Source: FTC Miracle Health Claims guidance; PMC12796600, 2024.